Brief: Ossdsign Launches Synthetic Bone Graft Catalyst In US - Karolinska
Aug 16 (Reuters) - Karolinska Development AB KDEV.ST :
* KAROLINSKA DEVELOPMENT'S PORTFOLIO COMPANY OSSDSIGN
LAUNCHES THE
SYNTHETIC BONE GRAFT OSSDSIGN CATALYST ON THE U.S. MARKET
* ADDRESSABLE MARKET FOR SYNTHETIC BONE GRAFTS IN SPINAL
SURGERIES
IS THUS SUBSTANTIAL AND IS VALUED AT USD 2.6 BLN
Source text for Eikon: ID:nGNE6cDQ9T
Further company coverage: KDEV.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Kdventures AB
See all newsRefile: BRIEF-Umecrine Cognition Gets Notice Of Allowance In US
Brief: KDventures' Modus Therapeutics Pauses Enrollment In Phase 2A Study
Brief: KDventures' AnaCardio Raises €62.5 Million
Brief: Kdventures' Umecrine Cognition Gets Two USPTO Notices Of Allowance For Patent Applications
Brief: Kdventures' Modus Therapeutics Carries Out Directed Issue